The Effects of Multi-Growth Factors-Containing Cream on Post-Thyroidectomy Scars: A Preliminary Study
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Growth factors play important roles in wound healing. However, the evidence for the effects of growth factors on post-thyroidectomy scars is limited. Objective: We performed a prospective study to assess the preventive and therapeutic effect of a multi-growth factor (MGF)-containing cream on post-thyroidectomy scars. Methods: Twenty-one patients with thyroidectomy scars applied MGF cream twice a day. We assessed the changes in erythema, pigmentation, skin elasticity, and skin hydration status using the erythema index, melanin index, cutometer, and corneometer, respectively. In addition, Vancouver scar scale (VSS) and patient satisfaction were assessed at 10 days after surgery (baseline), 2 weeks, 6 weeks, and 12 weeks after baseline. Results: The mean total VSS scores were significantly lower at 6 weeks (3.24±1.51 vs. 1.91±1.38) and 12 weeks (3.24±1.51 vs. 1.71±1.59) compared to the baseline. The degree of pigmentation was significantly lower at 12 weeks compared to the baseline, and the skin elasticity, and the skin hydration status were significantly higher at 12 weeks compared to the baseline. Over 85% of the patients were satisfied with the use of MGF cream without any adverse effect. Conclusion: MGF cream might have additive or supportive effect for scar formation after thyroidectomy.
Abstract
Background: Growth factors play important roles in wound healing. However, the evidence for the effects of growth factors on post-thyroidectomy scars is limited. Objective: We performed a prospective study to assess the preventive and therapeutic effect of a multi-growth factor (MGF)-containing cream on post-thyroidectomy scars. Methods: Twenty-one patients with thyroidectomy scars applied MGF cream twice a day. We assessed the changes in erythema, pigmentation, skin elasticity, and skin hydration status using the erythema index, melanin index, cutometer, and corneometer, respectively. In addition, Vancouver scar scale (VSS) and patient satisfaction were assessed at 10 days after surgery (baseline), 2 weeks, 6 weeks, and 12 weeks after baseline. Results: The mean total VSS scores were significantly lower at 6 weeks (3.24±1.51 vs. 1.91±1.38) and 12 weeks (3.24±1.51 vs. 1.71±1.59) compared to the baseline. The degree of pigmentation was significantly lower at 12 weeks compared to the baseline, and the skin elasticity, and the skin hydration status were significantly higher at 12 weeks compared to the baseline. Over 85% of the patients were satisfied with the use of MGF cream without any adverse effect. Conclusion: MGF cream might have additive or supportive effect for scar formation after thyroidectomy.
참고문헌 (26)
- Ahn HS, "Korea's thyroid-cancer "epidemic"--screening and overdiagnosis", N Engl J Med, 371, pp.1765~1767 (2014)
- Rahib L, "Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States", Cancer Res, 74, pp.2913~2921 (2014)
- American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer", Thyroid, 19, pp.1167~1214 (2009)
- Fonder MA, "Treating the chronic wound: a practical approach to the care of nonhealing wounds and wound care dressings", J Am Acad Dermatol, 58, pp.185~206 (2008)
- Sullivan T, "Rating the burn scar", J Burn Care Rehabil, 11, pp.256~260 (1990)
- Tuan TL, "The molecular basis of keloid and hypertrophic scar formation", Mol Med Today, 4, pp.19~24 (1998)
- Lumenta DB, "Internet-based survey on current practice for evaluation, prevention, and treatment of scars, hypertrophic scars, and keloids", Wound Repair Regen, 22, pp.483~491 (2014)
- Berman B, "Adjunct therapies to surgical management of keloids", Dermatol Surg, 22, pp.126~130 (1996)
- Ledon JA, "Intralesional treatment for keloids and hypertrophic scars: a review", Dermatol Surg, 39, pp.1745~1757 (2013)
- Guo S, "Factors affecting wound healing", J Dent Res, 89, pp.219~229 (2010)
- Diegelmann RF, "Wound healing: an overview of acute, fibrotic and delayed healing", Front Biosci, 9, pp.283~289 (2004)
- Broughton G 2nd, "The basic science of wound healing", Plast Reconstr Surg, 117(7 Suppl), pp.12S~34S (2006)
- Velnar T, "The wound healing process:an overview of the cellular and molecular mechanisms", J Int Med Res, 37, pp.1528~1542 (2009)
- Dejana E, "Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding", J Clin Invest, 75, pp.11~18 (1985)
- Grotendorst GR, "EGF and TGF-alpha are potent chemoattractants for endothelial cells and EGF-like peptides are present at sites of tissue regeneration", J Cell Physiol, 139, pp.617~623 (1989)
- Terranova VP, "Human endothelial cells are chemotactic to endothelial cell growth factor and heparin", J Cell Biol, 101, pp.2330~2334 (1985)
- Nanney LB, "Epidermal and dermal effects of epidermal growth factor during wound repair", J Invest Dermatol, 94, pp.624~629 (1990)
- Brown GL, "Enhancement of epidermal regeneration by biosynthetic epidermal growth factor", J Exp Med, 163, pp.1319~1324 (1986)
- Epstein JB, "The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy", Cancer, 89, pp.2258~2265 (2000)
- 김영석, "Effect of Recombinant Human Epidermal Growth Factor Against Cutaneous Scar Formation in Murine Full-thickness Wound Healing", Journal of Korean Medical Science, 25(4), pp.589~596 (2010), 대한의학회
- Steed DL, "Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group", J Vasc Surg, 21, pp.71~ (1995)
- Steed DL, "Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers", Plast Reconstr Surg, 117(7 Suppl), pp.143S~149S (2006)
- O'Brien L, "Silicon gel sheeting for preventing and treating hypertrophic and keloid scars", Cochrane Database Syst Rev, (1), pp.CD003826~ (2006)
- Meaume S, "Management of scars: updated practical guidelines and use of silicones", Eur J Dermatol, 24, pp.435~443 (2014)
- Hanasono MM, "The effect of silicone gel on basic fibroblast growth factor levels in fibroblast cell culture", Arch Facial Plast Surg, 6, pp.88~93 (2004)
- 최재훈, "Regulation of Transforming Growth Factor β1, Platelet-Derived Growth Factor, and Basic Fibroblast Growth Factor by Silicone Gel Sheeting in Early-Stage Scarring", Archives of Plastic Surgery, 42(1), pp.20~27 (2015), 대한성형외과학회